Clinical Trial Update: Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Korea evaluating optimized immunosuppression with everolimus and low-dose calcineurin inhibitors in heart transplant patients; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Heart Transplant | Phase 4 | Status: NOT_YET_RECRUITING